Rock Springs Capital Management LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$3.3B
Holdings
110
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (110 positions)
| Stock | Value |
|---|---|
GOSS 5 06/01/27GOSSAMER BIO INC | $4.0B |
SPRBSPRUCE BIOSCIENCES INC | $1.0B |
2L9BLUEPRINT MEDICINES CORP | $271.0M |
ISRGINTUITIVE SURGICAL INC | $132.0M |
NBIXNEUROCRINE BIOSCIENCES INC | $129.0M |
ARGXARGENX SE | $98.0M |
ACHCACADIA HEALTHCARE COMPANY IN | $79.0M |
RAREULTRAGENYX PHARMACEUTICAL IN | $79.0M |
EVHEVOLENT HEALTH INC | $77.0M |
MDGLMADRIGAL PHARMACEUTICALS INC | $68.0M |
FRPTFRESHPET INC | $62.0M |
BSXBOSTON SCIENTIFIC CORP | $62.0M |
MIRMMIRUM PHARMACEUTICALS INC | $60.0M |
ALNYALNYLAM PHARMACEUTICALS INC | $60.0M |
MRUSMERUS N V | $59.0M |
IDXXIDEXX LABS INC | $58.0M |
AGLAGILON HEALTH INC | $58.0M |
DC4DEXCOM INC | $56.0M |
HUMHUMANA INC | $55.0M |
IM8NINSMED INC | $54.0M |
RYTMRHYTHM PHARMACEUTICALS INC | $52.0M |
PHRPHREESIA INC | $51.0M |
TCE2CELLDEX THERAPEUTICS INC NEW | $51.0M |
EWEDWARDS LIFESCIENCES CORP | $50.0M |
XENEXENON PHARMACEUTICALS INC | $49.0M |
WSTWEST PHARMACEUTICAL SVSC INC | $47.0M |
PENPENUMBRA INC | $47.0M |
AGIOAGIOS PHARMACEUTICALS INC | $45.0M |
EXASEXACT SCIENCES CORP | $45.0M |
SRPTSAREPTA THERAPEUTICS INC | $44.0M |
IRTCIRHYTHM TECHNOLOGIES INC | $42.0M |
GPCRSTRUCTURE THERAPEUTICS INC | $41.0M |
ASNDASCENDIS PHARMA A/S | $39.0M |
PODDINSULET CORP | $39.0M |
RVMDREVOLUTION MEDICINES INC | $36.0M |
TVTXTRAVERE THERAPEUTICS INC | $36.0M |
AZTAAZENTA INC | $36.0M |
KYMRKYMERA THERAPEUTICS INC | $34.0M |
WRBYWARBY PARKER INC | $33.0M |
MREOMEREO BIOPHARMA GROUP PLC | $33.0M |
IMVTIMMUNOVANT INC | $31.0M |
AFWALIGN TECHNOLOGY INC | $30.0M |
AKROAKERO THERAPEUTICS INC | $25.0M |
JNJJOHNSON & JOHNSON | $24.0M |
LFSTLIFESTANCE HEALTH GROUP INC | $23.0M |
PCRXPACIRA BIOSCIENCES INC | $22.0M |
LEGNLEGEND BIOTECH CORP | $22.0M |
BCRXBIOCRYST PHARMACEUTICALS INC | $22.0M |
ZLABZAI LAB LTD | $22.0M |
NUVB/WSNUVATION BIO INC | $21.4M |
NVONOVO-NORDISK A S | $21.0M |
OSCROSCAR HEALTH INC | $19.0M |
KRYSKRYSTAL BIOTECH INC | $19.0M |
NUVLNUVALENT INC | $19.0M |
INSPINSPIRE MED SYS INC | $17.0M |
DYNDYNE THERAPEUTICS INC | $16.0M |
INZYINOZYME PHARMA INC | $16.0M |
PHVSPHARVARIS N V | $14.0M |
IMCRIMMUNOCORE HLDGS PLC | $14.0M |
DVAXDYNAVAX TECHNOLOGIES CORP | $14.0M |
VERAVERA THERAPEUTICS INC | $13.0M |
AM6AMICUS THERAPEUTICS INC | $12.0M |
CRNXCRINETICS PHARMACEUTICALS IN | $12.0M |
—OLINK HLDG AB | $12.0M |
CRLCHARLES RIV LABS INTL INC | $12.0M |
PRTAPROTHENA CORP PLC | $12.0M |
BMRNBIOMARIN PHARMACEUTICAL INC | $12.0M |
NVROEURNEVRO CORP | $11.0M |
CGEMCULLINAN THERAPEUTICS INC | $11.0M |
ELVNENLIVEN THERAPEUTICS INC | $10.0M |
JSPRJASPER THERAPEUTICS INC | $9.0M |
EDAEDAP TMS S A | $8.0M |
NVV1NOVAVAX INC | $8.0M |
ACCDEURACCOLADE INC | $8.0M |
NMRANEUMORA THERAPEUTICS INC. | $7.0M |
SWTXSPRINGWORKS THERAPEUTICS INC | $7.0M |
APLTAPPLIED THERAPEUTICS INC | $7.0M |
AUPHAURINIA PHARMACEUTICALS INC | $6.0M |
—MERSANA THERAPEUTICS INC | $6.0M |
BEAMBEAM THERAPEUTICS INC | $5.0M |
CMPXCOMPASS THERAPEUTICS INC | $5.0M |
APLSAPELLIS PHARMACEUTICALS INC | $5.0M |
ABOSACUMEN PHARMACEUTICALS INC | $5.0M |
BHVNBIOHAVEN LTD | $4.0M |
PLRXPLIANT THERAPEUTICS INC | $4.0M |
MGNXMACROGENICS INC | $4.0M |
LUNGPULMONX CORP | $4.0M |
FULCFULCRUM THERAPEUTICS INC | $4.0M |
MLYSMINERALYS THERAPEUTICS INC | $4.0M |
AUTLAUTOLUS THERAPEUTICS PLC | $3.0M |
EPIEURESSA PHARMA INC | $3.0M |
CATXPERSPECTIVE THERAPEUTICS INC | $3.0M |
ACRSACLARIS THERAPEUTICS INC | $3.0M |
SGMTSAGIMET BIOSCIENCES INC | $2.0M |
GOSSGOSSAMER BIO INC | $2.0M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $2.0M |
XLOXILIO THERAPEUTICS INC | $2.0M |
CYPHLEAP THERAPEUTICS INC | $2.0M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $2.0M |
CGENCOMPUGEN LTD | $1.0M |
Page 1 of 2Next